These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
729 related items for PubMed ID: 12732648
41. An inducible pathway for degradation of FLIP protein sensitizes tumor cells to TRAIL-induced apoptosis. Kim Y, Suh N, Sporn M, Reed JC. J Biol Chem; 2002 Jun 21; 277(25):22320-9. PubMed ID: 11940602 [Abstract] [Full Text] [Related]
42. Peroxisome proliferator-activated receptor activators inhibit lipopolysaccharide-induced tumor necrosis factor-alpha expression in neonatal rat cardiac myocytes. Takano H, Nagai T, Asakawa M, Toyozaki T, Oka T, Komuro I, Saito T, Masuda Y. Circ Res; 2000 Sep 29; 87(7):596-602. PubMed ID: 11009565 [Abstract] [Full Text] [Related]
44. FBI-1 enhances transcription of the nuclear factor-kappaB (NF-kappaB)-responsive E-selectin gene by nuclear localization of the p65 subunit of NF-kappaB. Lee DK, Kang JE, Park HJ, Kim MH, Yim TH, Kim JM, Heo MK, Kim KY, Kwon HJ, Hur MW. J Biol Chem; 2005 Jul 29; 280(30):27783-91. PubMed ID: 15917220 [Abstract] [Full Text] [Related]
47. Peroxisome proliferator-activated receptor (PPAR)-gamma expression in human vascular smooth muscle cells: inhibition of growth, migration, and c-fos expression by the peroxisome proliferator-activated receptor (PPAR)-gamma activator troglitazone. Benson S, Wu J, Padmanabhan S, Kurtz TW, Pershadsingh HA. Am J Hypertens; 2000 Jan 29; 13(1 Pt 1):74-82. PubMed ID: 10678274 [Abstract] [Full Text] [Related]
48. Suppression of NF-kappaB and GSK-3beta is involved in colon cancer cell growth inhibition by the PPAR agonist troglitazone. Ban JO, Kwak DH, Oh JH, Park EJ, Cho MC, Song HS, Song MJ, Han SB, Moon DC, Kang KW, Hong JT. Chem Biol Interact; 2010 Oct 06; 188(1):75-85. PubMed ID: 20540935 [Abstract] [Full Text] [Related]
52. Peroxisome proliferator-activated receptor gamma induces growth arrest and differentiation markers of human colon cancer cells. Kitamura S, Miyazaki Y, Shinomura Y, Kondo S, Kanayama S, Matsuzawa Y. Jpn J Cancer Res; 1999 Jan 06; 90(1):75-80. PubMed ID: 10076568 [Abstract] [Full Text] [Related]
54. Negative regulation of peroxisome proliferator-activated receptor-gamma gene expression contributes to the antiadipogenic effects of tumor necrosis factor-alpha. Zhang B, Berger J, Hu E, Szalkowski D, White-Carrington S, Spiegelman BM, Moller DE. Mol Endocrinol; 1996 Nov 06; 10(11):1457-66. PubMed ID: 8923470 [Abstract] [Full Text] [Related]
55. Rosiglitazone induction of Insig-1 in white adipose tissue reveals a novel interplay of peroxisome proliferator-activated receptor gamma and sterol regulatory element-binding protein in the regulation of adipogenesis. Kast-Woelbern HR, Dana SL, Cesario RM, Sun L, de Grandpre LY, Brooks ME, Osburn DL, Reifel-Miller A, Klausing K, Leibowitz MD. J Biol Chem; 2004 Jun 04; 279(23):23908-15. PubMed ID: 15073165 [Abstract] [Full Text] [Related]
56. Differential modulation of COX-2 expression in A549 airway epithelial cells by structurally distinct PPAR(gamma) agonists: evidence for disparate functional effects which are independent of NF-(kappa)B and PPAR(gamma). Patel KM, Wright KL, Whittaker P, Chakravarty P, Watson ML, Ward SG. Cell Signal; 2005 Sep 04; 17(9):1098-110. PubMed ID: 15993751 [Abstract] [Full Text] [Related]
57. Activation of peroxisome proliferator-activated receptor gamma inhibits interleukin-1beta-induced membrane-associated prostaglandin E2 synthase-1 expression in human synovial fibroblasts by interfering with Egr-1. Cheng S, Afif H, Martel-Pelletier J, Pelletier JP, Li X, Farrajota K, Lavigne M, Fahmi H. J Biol Chem; 2004 May 21; 279(21):22057-65. PubMed ID: 15023995 [Abstract] [Full Text] [Related]